DiMichele, Donna

Publications

Sort by

Co-Author Network

selected publications

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study. Haemophilia : the official journal of the World Federation of Hemophilia. 2015 Academic Article GET IT
Times cited: 20
Use of global assays to understand clinical phenotype in congenital factor VII deficiency. Haemophilia : the official journal of the World Federation of Hemophilia. 2013 Academic Article GET IT
Times cited: 10
Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC database. Haemophilia : the official journal of the World Federation of Hemophilia. 2012 Academic Article GET IT
Times cited: 16
The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Blood. 2012 Academic Article GET IT
Times cited: 87
Paroxysmal nocturnal hemoglobinuria in pediatric patients. Pediatric blood & cancer. 2011 Academic Article GET IT
Times cited: 33
The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood. 2011 Academic Article GET IT
Times cited: 345
Mutation in the factor VII hepatocyte nuclear factor 4α-binding site contributes to factor VII deficiency. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2011 Academic Article GET IT
Times cited: 7
Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia. 2011 Academic Article GET IT
Times cited: 10
Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia. Gene therapy. 2011 Academic Article GET IT
Times cited: 159
Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven®, a factor XI concentrate. 2011 GET IT
Times cited: 11
Neoangiogenesis contributes to the development of hemophilic synovitis. Blood. 2010 Academic Article GET IT
Times cited: 91
Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008). Haemophilia : the official journal of the World Federation of Hemophilia. 2010 Academic Article GET IT
Times cited: 12
The "parallel-cohort RCT": Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism. Contemporary clinical trials. 2009 Academic Article GET IT
Times cited: 22
Pharmacokinetics and safety of fibrinogen concentrate. Journal of thrombosis and haemostasis : JTH. 2009 Academic Article GET IT
Times cited: 99
Splenic infarction and subsequent splenic rupture in a patient with paroxysmal nocturnal hemoglobinuria and heparin-induced thrombocytopenia. 2009 GET IT
Times cited: 5
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project. Haemophilia : the official journal of the World Federation of Hemophilia. 2009 Academic Article GET IT
Times cited: 116
Risk factors for inhibitor formation in haemophilia: a prevalent case-control study. Haemophilia : the official journal of the World Federation of Hemophilia. 2009 Academic Article GET IT
Times cited: 61
Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia. 2009 Academic Article GET IT
Times cited: 26
Rare inherited disorders of fibrinogen. Haemophilia : the official journal of the World Federation of Hemophilia. 2008 Review GET IT
Times cited: 191
The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy. Haemophilia : the official journal of the World Federation of Hemophilia. 2008 Academic Article GET IT
Times cited: 75
Power Doppler sonography in the diagnosis of hemophilic synovitis--a promising tool. Journal of thrombosis and haemostasis : JTH. 2008 Academic Article GET IT
Times cited: 60
Haemophilia in the first years of life. Haemophilia : the official journal of the World Federation of Hemophilia. 2008 Academic Article GET IT
Times cited: 28
A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation. Pediatric blood & cancer. 2008 Academic Article GET IT
Times cited: 18
The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile. Haemophilia : the official journal of the World Federation of Hemophilia. 2007 Academic Article GET IT
Times cited: 48
Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia. 2007 Academic Article GET IT
Times cited: 47
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. The New England journal of medicine. 2007 Academic Article GET IT
Times cited: 1511
Inhibitor development in haemophilia B: an orphan disease in need of attention. British journal of haematology. 2007 Review GET IT
Times cited: 200
Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach. Journal of thrombosis and haemostasis : JTH. 2007 Review GET IT
Times cited: 35
International workshop on immune tolerance induction: consensus recommendations. Haemophilia : the official journal of the World Federation of Hemophilia. 2007 Conference Paper GET IT
Times cited: 230
Immune tolerance: critical issues of factor dose, purity and treatment complications. Haemophilia : the official journal of the World Federation of Hemophilia. 2006 Review GET IT
Times cited: 27
Inhibitor treatment in haemophilias A and B: inhibitor diagnosis. Haemophilia : the official journal of the World Federation of Hemophilia. 2006 Review GET IT
Times cited: 24
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia : the official journal of the World Federation of Hemophilia. 2006 Academic Article GET IT
Times cited: 76
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood. 2006 Academic Article GET IT
Times cited: 366
The international immune tolerance study: a multicenter prospective randomized trial in progress. Journal of thrombosis and haemostasis : JTH. 2006 Letter GET IT
Times cited: 58
A retrospective postlicensure survey of FEIBA efficacy and safety. Haemophilia : the official journal of the World Federation of Hemophilia. 2006 Academic Article GET IT
Times cited: 104
Ethical issues in haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia. 2006 Review GET IT
Times cited: 13
Management of factor VIII inhibitors. International journal of hematology. 2006 Review GET IT
Times cited: 26
High frequency of premature termination mutations in the factor V gene: three factor V deficiency case reports and a mutation review. 2005 GET IT
Times cited: 10
Inhibitors in haemophilia: clinical aspects. Haemophilia : the official journal of the World Federation of Hemophilia. 2004 Review GET IT
Times cited: 53
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia. 2004 Academic Article GET IT
Times cited: 138
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. Journal of thrombosis and haemostasis : JTH. 2004 Academic Article GET IT
Times cited: 245
Management of pregnancy in a patient with severe haemophilia A. 2003 GET IT
Times cited: 28
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia : the official journal of the World Federation of Hemophilia. 2003 Academic Article GET IT
Times cited: 33
Gene therapy ethics and haemophilia: an inevitable therapeutic future?. Haemophilia : the official journal of the World Federation of Hemophilia. 2003 Review GET IT
Times cited: 20
Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa. 2001 GET IT
Times cited: 36

more ...

less ...

Background

education and training

M.D., McGill University Faculty of Medicine (Canada) 1978

Contact

full name

Donna DiMichele

primary email

dmdimich@med.cornell.edu

VIVO Weill Cornell Medical College

Donna DiMichele Clinical Professor of Pediatrics

Publications

selected publications

Background

education and training

Contact

full name

primary email